$9.97
-0.53-5.05%
Last update: Jul 20, 3:15 PM
Fennec Pharmaceuticals Inc Earnings Estimates
FENCNASDAQ
Fennec Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:FENC
Fennec Pharmaceuticals (FENC) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $0.02 and quarterly revenue of $16.09M.
In the most recent quarter (Q1), Fennec Pharmaceuticals reported EPS of $0.01, beating estimates of $-0.02 by 1.50%. Revenue came in at $15.11M, exceeding the estimate of $13.86M by 0.09%.
Over the last 4 quarters, Fennec Pharmaceuticals has averaged an EPS surprise of 2.28% and a revenue surprise of 0.07%.
Earnings Date
Aug 13
EPS Estimate
$0.020
Quarterly Revenue Estimate
$16.09M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$51.00M
Fennec Pharmaceuticals Earnings History
Analyze the earnings history of Fennec Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Fennec Pharmaceuticals (FENC) Earnings Per Share
The chart below shows Fennec Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Fennec Pharmaceuticals (FENC) Revenue
The chart below shows Fennec Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Fennec Pharmaceuticals (NASDAQ:FENC) reporting earnings?
Fennec Pharmaceuticals (FENC) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Fennec Pharmaceuticals (NASDAQ:FENC)?
The Actual EPS was $0.01, which beat the estimate of $-0.02.
What were Fennec Pharmaceuticals’s (NASDAQ:FENC) revenues?
The Actual Revenue was $15.11M, which beat the estimate of $13.86M.
